These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. New protease inhibitor offers clinicians hope for better salvage therapy. Murphy MJ HIV Clin; 2006; 18(1):1-3. PubMed ID: 16838417 [No Abstract] [Full Text] [Related]
14. Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistance. Luna B; Townsend MU Clin Ther; 2007 Nov; 29(11):2309-18. PubMed ID: 18158073 [TBL] [Abstract][Full Text] [Related]
15. Tipranavir: a new protease inhibitor for the treatment of antiretroviral-experienced HIV-infected patients. de Mendoza C; Morelló J; Garcia-Gascó P; Rodríguez-Novoa S; Soriano V Expert Opin Pharmacother; 2007 Apr; 8(6):839-50. PubMed ID: 17425479 [TBL] [Abstract][Full Text] [Related]
16. Tipranavir (Aptivus) for HIV. Med Lett Drugs Ther; 2005 Oct; 47(1219):83-4. PubMed ID: 16247341 [TBL] [Abstract][Full Text] [Related]
17. FDA approval: tipranavir. Sax PE AIDS Clin Care; 2005 Aug; 17(8):78. PubMed ID: 16193574 [No Abstract] [Full Text] [Related]
18. New black box warning for ritonavir-boosted tipranavir. Ryan CT AIDS Clin Care; 2006 Aug; 18(8):72. PubMed ID: 16906669 [No Abstract] [Full Text] [Related]
19. Tipranavir: a protease inhibitor for HIV salvage therapy. Dong BJ; Cocohoba JM Ann Pharmacother; 2006; 40(7-8):1311-21. PubMed ID: 16788094 [TBL] [Abstract][Full Text] [Related]
20. Tipranavir: new drug. HIV protease inhibitor. A last resort. Prescrire Int; 2006 Dec; 15(86):217-9. PubMed ID: 17167925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]